
Dx Deals: QuidelOrtho Acquires LEX Diagnostics, Plans to Switch Out Respiratory Testing Platforms
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
The pandemic may have set the stage for a jump in infections from these four nemeses
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.
No company better embodies the vicissitudes of running a COVID-19-focused diagnostics business during the pandemic period than Lucira Health.